<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font14 { font-size : 14; } .font15 { font-size : 15; } .font16 { font-size : 16; } .font17 { font-size : 17; } .font20 { font-size : 20; } .font22 { font-size : 22; } .font23 { font-size : 23; } .font24 { font-size : 24; } .font25 { font-size : 25; } .font28 { font-size : 28; } .font30 { font-size : 30; } .font31 { font-size : 31; }</style>
 <body>
  <p>
   <span class="font31">−. kcal mol </span>
   <span class="font30">PD- </span>
   <span class="font28">residues </span>
   <span class="font25">residue </span>
   <span class="font25">interaction </span>
   <span class="font24">pembrolizumab </span>
   <span class="font23">receptor </span>
   <span class="font22">binding </span>
   <span class="font22">immune </span>
   <span class="font20">energy </span>
   <span class="font20">cancer </span>
   <span class="font20">hydrogen </span>
   <span class="font17">interactions </span>
   <span class="font17">{border-style </span>
   <span class="font17">−), </span>
   <span class="font16">px;} </span>
   <span class="font16">quantum </span>
   <span class="font16">#ffffff;} </span>
   <span class="font16">amino-acids </span>
   <span class="font16">cell </span>
   <span class="font15">heavy-chain </span>
   <span class="font15">protein </span>
   <span class="font15">Chem. </span>
   <span class="font15">Figure </span>
   <span class="font15">cells </span>
   <span class="font15">complex </span>
   <span class="font15">bonds </span>
   <span class="font14">. kcal mol </span>
   <span class="font14">checkpoint </span>
   <span class="font14">energies </span>
   <span class="font14">human </span>
   <span class="font14">molecular </span>
   <span class="font14">new </span>
   <span class="font14">number </span>
   <span class="font14">important </span>
   <span class="font14">light-chain </span>
   <span class="font14">energetic </span>
   <span class="font14">surface </span>
   <span class="font13">Cancer </span>
   <span class="font13">Fig. </span>
   <span class="font13">PD-L </span>
   <span class="font13">amino-acid </span>
   <span class="font13">development </span>
   <span class="font13">drug </span>
   <span class="font13">radius </span>
   <span class="font13">recognition </span>
   <span class="font13">results </span>
   <span class="font13">&amp;gt; </span>
   <span class="font13">charged </span>
   <span class="font13">including </span>
   <span class="font13">programmed </span>
   <span class="font13">shown </span>
   <span class="font13">targeting </span>
   <span class="font13">therapeutic </span>
   <span class="font13">−). </span>
   <span class="font12">Pembrolizumab </span>
   <span class="font12">Phys. </span>
   <span class="font12">based </span>
   <span class="font12">bond </span>
   <span class="font12">formed </span>
   <span class="font12">group </span>
   <span class="font12">non-conventional </span>
   <span class="font12">pocket </span>
   <span class="font12">px; </span>
   <span class="font12">relevant </span>
   <span class="font12">treatment </span>
   <span class="font12">tumor </span>
   <span class="font12">{font-family </span>
   <span class="font12">. Å </span>
   <span class="font12">MFCC </span>
   <span class="font12">PD-, </span>
   <span class="font12">account </span>
   <span class="font12">antibody </span>
   <span class="font12">blockade </span>
   <span class="font12">cells, </span>
   <span class="font12">death </span>
   <span class="font12">direct </span>
   <span class="font12">font-size </span>
   <span class="font12">functional </span>
   <span class="font12">ligands </span>
   <span class="font12">mainly </span>
   <span class="font12">making </span>
   <span class="font12">molecules </span>
   <span class="font12">pair </span>
   <span class="font12">pairs </span>
   <span class="font12">scheme </span>
   <span class="font12">structural </span>
   <span class="font12">study </span>
   <span class="font12">used </span>
   <span class="font12">using </span>
   <span class="font12">water-mediated </span>
   <span class="font12">Structural </span>
   <span class="font12">Zhang </span>
   <span class="font12">amine </span>
   <span class="font12">associated </span>
   <span class="font12">attractive </span>
   <span class="font12">calculated </span>
   <span class="font12">caps </span>
   <span class="font12">clinical </span>
   <span class="font12">crystallographic </span>
   <span class="font12">dielectric </span>
   <span class="font12">double; </span>
   <span class="font12">fragment </span>
   <span class="font12">immunotherapy </span>
   <span class="font12">individual </span>
   <span class="font12">mechanism </span>
   <span class="font12">pathway </span>
   <span class="font12">pharmaceutical </span>
   <span class="font12">potential </span>
   <span class="font12">related </span>
   <span class="font12">relevance </span>
   <span class="font12">residues. </span>
   <span class="font12">respectively. </span>
   <span class="font12">shows </span>
   <span class="font12">side-chain </span>
   <span class="font12">structure </span>
   <span class="font11">Nat. </span>
   <span class="font11">PD-. </span>
   <span class="font11">Pembrolizumab/PD- </span>
   <span class="font11">Structure </span>
   <span class="font11">antibodies </span>
   <span class="font11">biochemistry </span>
   <span class="font11">border-color </span>
   <span class="font11">border-width </span>
   <span class="font11">bound </span>
   <span class="font11">calculations </span>
   <span class="font11">chemistry </span>
   <span class="font11">constant </span>
   <span class="font11">design </span>
   <span class="font11">domain </span>
   <span class="font11">drugs </span>
   <span class="font11">extracellular </span>
   <span class="font11">form </span>
   <span class="font11">hydrophobic </span>
   <span class="font11">involved </span>
   <span class="font11">makes </span>
   <span class="font11">order </span>
   <span class="font11">pembrolizumab/PD- </span>
   <span class="font11">performed </span>
   <span class="font11">point </span>
   <span class="font11">position </span>
   <span class="font11">resistance </span>
   <span class="font11">salt </span>
   <span class="font11">signaling </span>
   <span class="font11">solid; </span>
   <span class="font11">strong </span>
   <span class="font11">strongest </span>
   <span class="font11">sum </span>
   <span class="font11">total </span>
   <span class="font11">types </span>
   <span class="font11">understanding </span>
   <span class="font11">weak </span>
   <span class="font11">{font-style </span>
   <span class="font11">{font-weight </span>
   <span class="font11">ε =  </span>
   <span class="font11">(PD-) </span>
   <span class="font11">Commons </span>
   <span class="font11">Comput. </span>
   <span class="font11">Creative </span>
   <span class="font11">C’D </span>
   <span class="font11">Fab </span>
   <span class="font11">However, </span>
   <span class="font11">J.X.L.N. </span>
   <span class="font11">Med. </span>
   <span class="font11">Nature </span>
   <span class="font11">PD-/PD-L </span>
   <span class="font11">Quantum </span>
   <span class="font11">Rev. </span>
   <span class="font11">Sci. </span>
   <span class="font11">Thus, </span>
   <span class="font11">advanced </span>
   <span class="font11">affinity </span>
   <span class="font11">analysis </span>
   <span class="font11">antibody-based </span>
   <span class="font11">approved </span>
   <span class="font11">basis </span>
   <span class="font11">bold </span>
   <span class="font11">bonds. </span>
   <span class="font11">bridge </span>
   <span class="font11">calculation </span>
   <span class="font11">carbonyl </span>
   <span class="font11">contacts </span>
   <span class="font11">contribution </span>
   <span class="font11">courier; </span>
   <span class="font11">density </span>
   <span class="font11">depicts </span>
   <span class="font11">different </span>
   <span class="font11">dispersion </span>
   <span class="font11">em; </span>
   <span class="font11">expressed </span>
   <span class="font11">features </span>
   <span class="font11">function </span>
   <span class="font11">highest </span>
   <span class="font11">hydroxyl </span>
   <span class="font11">increase </span>
   <span class="font11">inhibition </span>
   <span class="font11">leading </span>
   <span class="font11">lines </span>
   <span class="font11">loop </span>
   <span class="font11">lung </span>
   <span class="font11">model </span>
   <span class="font11">namely: </span>
   <span class="font11">observed </span>
   <span class="font11">one, </span>
   <span class="font11">previous </span>
   <span class="font11">proteins </span>
   <span class="font11">provide </span>
   <span class="font11">pt;} </span>
   <span class="font11">receptor. </span>
   <span class="font11">region </span>
   <span class="font11">residue-residue </span>
   <span class="font11">response </span>
   <span class="font11">responsible </span>
   <span class="font11">second </span>
   <span class="font11">set </span>
   <span class="font11">solvation </span>
   <span class="font11">taking </span>
   <span class="font11">tolerance </span>
  </p>
 </body>
</html>
